|COVID–19 NEWS||India sets new global record of 414,188 daily COVID cases | COVID-19 still complicated in Southeast Asia | Perak residents advised to be vigilant following detection of South African variant | China's CoronaVac Vaccine Safe: Azerbaijani acting Health Minister | EMCO in 16 localities in Sg Ruan, seven in Sempalit, Pahang from May 8-21 ||
By Linda Khoo Hui Li
BANGKOK, April 20 -- Thailand recorded 1,443 new COVID-19 cases and four deaths over the last 24 hours, bringing the tally in the kingdom to 45,185 and 108 fatalities thus far.
Centre for COVID-19 Situation Administration (CCSA) spokesman Dr Taweesin Visanuyothin said a total of 1,441 local transmission have been reported, including 350 cases in Bangkok followed by Chiang Mai (116), Chonburi (82), Samut Prakan (60) and Pathum Thani (57). Two imported cases were also reported.
“A total of 16, 322 cases have been recorded so far this month alone.
“To date, a total of 222 COVID-19 patients developed severe symptoms and the number of patients on ventilators have increased to 55,” he said at the COVID-19 briefing here today.
The four deaths involved two Thai men aged 78 years old and 30 years old, a 78-year-old Thai woman, and an 86-year-old Indian woman.
Meanwhile, Deputy Prime Minister and Public Health Minister Anutin Charnvirakul said all COVID-19 patients in the kingdom should be admitted and treated at hospitals to reduce transmission.
He assured that there were enough hospitals beds for COVID-19 patients despite the rising number of cases.
“Patients do not have to go into self-isolation or try to treat themselves as there are plenty of beds available at hospitals and field hospitals.
“All patients can be treated and medical staff can monitor their symptoms,” he was quoted as saying by The Nation.
Meanwhile, Thailand’s Food and Drug Administration (FDA) has given the green light to three private firms to import and register for COVID-19 vaccines.
The secretary-general of FDA, Dr Paisan Dankhum said a total of 14 companies had applied to import COVID-19 vaccines.
“The FDA has been carefully considering all candidates with a focus on public safety and health,” he said as quoted by The Nation.
To date, Government Pharmaceutical Organisation (GPO) is the sole importer of COVID-19 vaccines.